SHL Group is proud to introduce SHL Pharma, a facility built with a greener approach providing final assembly, labeling and …
A third of patients with diabetes admit to regularly missing or not taking insulin treatment three days a month, according …
The debt crisis afflicting Greece is starting to affect the country’s hospitals as pharma companies refuse to deliver drugs. Roche …

Novartis’ drug Votubia has been recommended by regulators to treat a disease for which the only current option in Europe …
The BMA has hit out against reckless cuts to health service budgets and a ‘phoney war’ on NHS pensions. In …
The European Medicines Agency has approved a second manufacturing facility in the USA for Shire’s Fabry disease treatment Replagal. Shire’s …
GlaxoSmithKline has agreed to pay almost $41 million to dozens of US states in a lawsuit focusing on alleged substandard …
Abbott delays closure of Canadian facility, West Pharma starts a new build in China, plus updates from Vetter, Pharmadule and …
Sanofi has promoted Peter Guenter to senior vice president, Europe, with effect from 15 July. He is currently general manager …
SERVICE INSIGHT A successful health technology assessment is critical for market access in the UK. However, submissions that don’t follow …
Pfizer is selling its Irish manufacturing facility in Shanbally, Cork, to US biopharmaceutical company BioMarin for $48.5 million, creating up …
Activaero GmbH has appointed Christian Pangratz as chief business officer, with a brief to lead its business development, marketing and …

Boehringer Ingelheim and Eli Lilly’s new type II diabetes drug Trajenta has been recommended for European approval. It was given …
The influential British Medical Journal has called on the government to abandon its healthcare reform bill, which it says has …
I speak about social media and pharma company communications all the time. I find myself talking about it not just …

Novo Nordisk plans to invest almost 1 billion Danish kroner (134 million euros) in a new biologics manufacturing facility at …
Health PR specialist Chamberlain Communications Group is to come under the umbrella of Chandler Chicco Companies (CCC) as a prelude …

Pfizer has made the surprise decision to retain 350 jobs at its research and development site in Sandwich, Kent, providing …

Roche and Evotec are to collaborate to find biomarkers for Roche oncology drugs under development. Roche has been one of …